Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease
G Tec Nefrol Dial
.
2017 Apr;29(2):80-84.
doi: 10.5301/GTND.2017.17029.
Epub 2018 Mar 13.
Author
Riccardo Magistroni
1
Affiliation
1
Divisione di Nefrologia Dialisi e Trapianto, Azienda Ospedaliero Universitaria Policlinico di Modena, Università di Modena e Reggio Emilia, Modena.
PMID:
29899594
PMCID:
PMC5992737
DOI:
10.5301/GTND.2017.17029
No abstract available
Keywords:
ADPKD; End-stage renal failure; Genetic; Kidney; Tolvaptan.
Publication types
Editorial